Bioject Medical Technologies Inc. of Portland, Ore., namedPeggy J. Miller vice president and chief financial officer,replacing James A. Kinkade, who is leaving to pursue otherbusiness interests. Miller was vice president for finance atOregon Health Sciences University.
AgriDyne Technologies Inc. of Salt Lake City said David F.Martin resigned as executive vice president and generalmanager of agricultural and specialty chemicals.
Luc Montagnier, who discovered the virus that causes AIDS,has joined the medical and scientific advisory board of AppliedImmune Sciences Inc. of Santa Clara, Calif.
Glycomed Inc. of Alameda, Calif., said that John Groom,president and chief executive officer of Athena NeurosciencesInc., was elected to Glycomed's board of directors.
Marilyn C. Bracken was named vice president of marketing andbusiness development of the Environmental Science Group ofApplied Bioscience International Inc. of East Millstone, N.J.
Cibus Pharmaceutical Inc. of Redwood City, Calif., named to itsboard of directors William F. Lalor, retired president of ICIPharmaceuticals Group, and Digby Barrios, former presidentand chief executive officer of Boehringer Ingelheim Corp.
Mary Beals was named director of corporate communications atCytogen Corp. of Princeton, N.J. She was director of commercialdevelopment, oncology and government relations, at Bristol-Myers Squibb Co.
SangStat Medical Corp. named Robert C. Floc'h general managerof SangStat's French subsidiary, SangStat Atlantique. Floc'h wasdirector of biopharmaceutical research and development atRhone Poulenc Group.
Kenneth D. Krantz was named vice president of clinical andregulatory affairs at ImClone Systems Inc. of New York. He wasexecutive director of clinical research for the biotechnologydivision of the R.W. Johnson Pharmaceutical Research Institute,a Johnson & Johnson company.
NeoRx Corp. of Seattle promoted Robert W. Schroff to vicepresident, general manager of cardiovascular products fromdirector, business development and analytical laboratories.NeoRx also promoted John M. Reno to vice president, researchand development from director of product development.
ImmuLogic Pharmaceutical Corp. of Cambridge, Mass., namedChristopher Nicodemus senior director of medical affairs andSean Evans director of formulations and drug delivery.Nicodemus was senior associate medical director at PfizerLaboratories in New York. Evans was a research scientist in thedepartment of pharmaceutics research and development atBristol-Myers Squibb Co. The company also named Heidi Wylevice president of marketing and business development. Shewas manager of marketing and business development.
Theragenics Corp. of Atlanta named to its board of directorsCharles R. Klimkowsky, senior vice president of the ChicagoCorporation.
Anergen Inc. of Redwood City, Calif., said Brian R. Clark, acompany founder and vice president for scientific developmenthas resigned to pursue other interests. The company said theposition will not be replaced.
Synergen Inc. of Boulder, Colo., named Giles V. Campionassociate director, clinical research, and Kathleen JoannaTufnell associate director, regulatory affairs in Europe. Campionwas the head of the rheumaology research section at HoechstAG in Germany. Tuffnell was principal pharmaceutical officer inthe biological unit at Medicines Control Agency in the UnitedKingdom.
(c) 1997 American Health Consultants. All rights reserved.